Singh; Shalini

Patent Applications and Registrations

Patent applications and USPTO patent grants for Singh; Shalini.The latest application filed is for "image analysis for breast cancer prognosis".

Company Profile

6.5.14

Singh; Shalini - Tucson AZ
Singh; Shalini - Uppsala SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Image Analysis for Breast Cancer Prognosis App 20220051804 - Chukka; Srinivas ; et al.	2022-02-17
Image analysis for breast cancer prognosis Grant 11,211,167 - Chukka , et al. December 28, 2	2021-12-28
Pharmaceutical Formulation App 20210346277 - Boyer; Scott ; et al.	2021-11-11
Materials And Methods For Performing Histochemical Assays For Human Pro-epiregulin And Amphiregulin App 20210063403 - Couto; Fernando Jose Rebelo do ; et al.	2021-03-04
Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulin Grant 10,852,304 - Couto , et al. December 1, 2	2020-12-01
Systems and methods for co-expression analysis in immunoscore computation Grant 10,755,406 - Barnes , et al. A	2020-08-25
Method Of Identifying Treatment Responsive Non-small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (alk) As A Marker App 20200225237 - Barnes; Michael ; et al.	2020-07-16
Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker Grant 10,620,207 - Grogan , et al.	2020-04-14
Compositions And Methods For Prognosing And Treating Colorectal Cancer App 20190269716 - Herrmann; Pia ; et al.	2019-09-05
Materials And Methods For Performing Histochemical Assays For Human Pro-epiregulin And Amphiregulin App 20180196057 - Couto; Fernando Jose Rebelo do ; et al.	2018-07-12
Systems And Methods For Co-expression Analysis In Immunoscore Computation App 20170309021 - Barnes; Michael ; et al.	2017-10-26
Method Of Identifying Treatment Responsive Non-small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (alk) As A Marker App 20170205416 - Grogan; Thomas ; et al.	2017-07-20
Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker Grant 9,651,555 - Grogan , et al. May 16, 2	2017-05-16
G-Alpha Interacting Vesicle Associated Protein (GIV) as a Predictive Marker in Stage II Colorectal Cancer App 20170038385 - Leith; Katherine ; et al.	2017-02-09
Simultaneous Detection Of Mutational Status And Gene Copy Number App 20160130666 - SINGH; SHALINI ; et al.	2016-05-12
Image Analysis for Breast Cancer Prognosis App 20150347702 - Chukka; Srinivas ; et al.	2015-12-03
Method of Identifying Treatment Responsive Non-Small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (ALK) as a Marker App 20150346206 - GROGAN; Thomas ; et al.	2015-12-03
Simultaneous Detection Of Mutational Status And Gene Copy Number App 20120264127 - Singh; Shalini ; et al.	2012-10-18
Methods Of Scoring Gene Copy Number In A Biological Sample Using In Situ Hybridization App 20120141472 - Singh; Shalini ; et al.	2012-06-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.